MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $175,000 | -33.7% | 156,195 | -33.7% | 0.05% | -50.5% |
| Q1 2022 | $264,000 | -29.2% | 235,515 | +1.0% | 0.11% | -27.8% |
| Q4 2021 | $373,000 | -57.9% | 233,183 | -36.2% | 0.15% | -69.8% |
| Q3 2021 | $885,000 | -31.2% | 365,661 | -9.9% | 0.50% | -12.9% |
| Q2 2021 | $1,287,000 | +118.1% | 405,871 | +131.9% | 0.57% | +78.3% |
| Q1 2021 | $590,000 | -41.1% | 175,000 | -37.5% | 0.32% | -44.7% |
| Q4 2020 | $1,002,000 | – | 280,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |